Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.
Liu J, Hu Y, Xie X, Fu J.
Ann Thorac Surg. 2012 Feb;93(2):423-7. Epub 2011 Dec 16.
Related citations
Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma.
Colley HE, Hearnden V, Jones AV, Weinreb PH, Violette SM, Macneil S, Thornhill MH, Murdoch C.
Br J Cancer. 2011 Nov 8;105(10):1582-92. doi: 10.1038/bjc.2011.403. Epub 2011 Oct 11.
Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.
Chan YW, Chow VL, Wei WI.
Cancer. 2011 Dec 16. doi: 10.1002/cncr.26719. [Epub ahead of print]
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children.
White-Koning M, Civade E, Geoerger B, Thomas F, Le Deley MC, Hennebelle I, Delord JP, Chatelut E, Vassal G.
Clin Cancer Res. 2011 Jul 15;17(14):4862-71. Epub 2011 Jun 8.
MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
Abraham D, Jackson N, Gundara JS, Zhao J, Gill AJ, Delbridge L, Robinson BG, Sidhu SB.
Clin Cancer Res. 2011 Jul 15;17(14):4772-81. Epub 2011 May 27.
Prospective randomized trial of high versus low negative pressure suction in management of chyle fistula after neck dissection for metastatic thyroid carcinoma.
Wu G, Chang X, Xia Y, Huang W, Koch WM.
Head Neck. 2011 Dec 16. doi: 10.1002/hed.21979. [Epub ahead of print]
Thyroid gland involvement in advanced laryngeal cancer: Association with clinical and pathologic characteristics.
Hilly O, Raz R, Vaisbuch Y, Strenov Y, Segal K, Koren R, Shvero J.
Head Neck. 2011 Dec 16. doi: 10.1002/hed.21972. [Epub ahead of print]
Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck.
Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Scharpf J, Ives DI.
Head Neck. 2011 Dec 16. doi: 10.1002/hed.21971. [Epub ahead of print]
Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer.
Nakamura T, Fuwa N, Takayama K, Inokuchi H, Tomoda T, Takada A, Makita C, Shiomi M, Yokouchi JI, Watanabe K.
Head Neck. 2011 Dec 16. doi: 10.1002/hed.21983. [Epub ahead of print]
DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors.
Lima LM, de Souza LR, da Silva TF, Pereira CS, Guimarães AL, de Paula AM, de Andrade Carvalho H.
Histopathology. 2012 Feb;60(3):489-96. doi: 10.1111/j.1365-2559.2011.04062.x. Epub 2011 Dec 16.
Unusual thyroid carcinoma with excessive extracellular hyaline globules: a case of "hyalinizing papillary carcinoma".
Kondo T, Nakazawa T, Terada N, Nakazawa K, Kawasaki T, Mochizuki K, Yamane T, Ohno S, Katoh R.
Hum Pathol. 2012 Jun;43(6):932-8. Epub 2011 Dec 15.
Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
Ishii H, Takahara M, Nagato T, Kis LL, Nagy N, Kishibe K, Harabuchi Y, Klein E.
Int J Cancer. 2012 Jan 1;130(1):48-58. doi: 10.1002/ijc.25969. Epub 2011 May 25.
Endothelin-1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal-epithelial interactions.
Hinsley EE, Hunt S, Hunter KD, Whawell SA, Lambert DW.
Int J Cancer. 2012 Jan 1;130(1):40-7. doi: 10.1002/ijc.25968. Epub 2011 Apr 13.
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
Wong VC, Chen H, Ko JM, Chan KW, Chan YP, Law S, Chua D, Kwong DL, Lung HL, Srivastava G, Tang JC, Tsao SW, Zabarovsky ER, Stanbridge EJ, Lung ML.
Int J Cancer. 2012 Jan 1;130(1):83-95. doi: 10.1002/ijc.25970. Epub 2011 Apr 20.
Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.
Muraki C, Ohga N, Hida Y, Nishihara H, Kato Y, Tsuchiya K, Matsuda K, Totsuka Y, Shindoh M, Hida K.
Int J Cancer. 2012 Jan 1;130(1):59-70. doi: 10.1002/ijc.25976. Epub 2011 Apr 20.
Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN.
J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7. Epub 2011 Aug 31.
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology?
Lippolis PV, Tognini S, Materazzi G, Polini A, Mancini R, Ambrosini CE, Dardano A, Basolo F, Seccia M, Miccoli P, Monzani F.
J Clin Endocrinol Metab. 2011 Nov;96(11):E1826-30. Epub 2011 Aug 24.
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer.
Capezzone M, Cantara S, Marchisotta S, Busonero G, Formichi C, Benigni M, Capuano S, Toti P, Pazaitou-Panayiotou K, Caruso G, Carli AF, Palummo N, Pacini F.
J Clin Endocrinol Metab. 2011 Nov;96(11):E1852-6. Epub 2011 Aug 24.
Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules.
Li H, Robinson KA, Anton B, Saldanha IJ, Ladenson PW.
J Clin Endocrinol Metab. 2011 Nov;96(11):E1719-26. Epub 2011 Aug 24.
MicroRNAs in thyroid cancer.
de la Chapelle A, Jazdzewski K.
J Clin Endocrinol Metab. 2011 Nov;96(11):3326-36. Epub 2011 Aug 24. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on